COVID-19 vaccine navigation for rheumatology patients
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study looks at helping Black and Latinx adults with autoimmune rheumatic diseases get the updated COVID-19 vaccine. It offers information and support (like testimonials and navigation help) to see what works best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a known autoimmune rheumatic disease (like lupus, rheumatoid arthritis, etc.)
- You identify as Black race and/or Latinx ethnicity
- You have not yet received the updated COVID-19 vaccine series
- You have access to a phone
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects health information from adults with certain autoimmune conditions who are currently using (or have been recommended) biologic or DMARD medicines. It may help researchers better understand these diseases and how treatments affect people over time.
This study looks at whether reaching out directly to patients with inflammatory arthritis can help them get rheumatology care faster. If you join, you might get extra support to access a specialist.
This study tests the safety and immune response of a dengue vaccine in people aged 12–59 with stable autoimmune rheumatic diseases (like rheumatoid arthritis or lupus) who are on low-dose or no immune-suppressing medications. It also includes healthy volunteers for comparison.
This trial tests whether watching personalized story videos along with informational videos can encourage older adults to get recommended vaccines. It aims to see if these videos are more effective than standard information alone.
This study tests whether connecting with friends and health workers can help more Latino people in Maryland get vaccinated or boosted against COVID-19. It aims to reach both those who are already vaccinated and those who are hesitant.
This study looks at community-based ways to help Latino adults ages 50 and older in San Francisco and Daly City get the RSV vaccine. The goal is to learn what works best to increase vaccination rates.
Hear when a new Rheumatologic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.